AFLAC Incorporated  

(Public, NYSE:AFL)   Watch this stock  
Find more results for AFL
+0.44 (0.70%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 62.52 - 63.23
52 week 48.56 - 67.62
Open 62.52
Vol / Avg. 0.00/1.89M
Mkt cap 28.67B
P/E 9.34
Div/yield 0.37/2.35
EPS 6.75
Shares 454.78M
Beta 1.97
Inst. own 67%
May 22, 2014
Aflac Incorporated Financial Analyst Briefing Add to calendar
May 5, 2014
Aflac Incorporated Annual Shareholder Meeting Add to calendar
Apr 30, 2014
Q1 2014 Aflac Incorporated Earnings Conference Call Add to calendar
Apr 29, 2014
Q1 2014 Aflac Incorporated Earnings Release - 4:00PM EDT - Add to calendar
Mar 3, 2014
Aflac Incorporated at Raymond James Financial Inc Institutional Investors Conference
Feb 13, 2014
Aflac Incorporated at Bank of America Merrill Lynch Insurance Conference
Feb 5, 2014
Q4 2013 Aflac Incorporated Earnings Conference Call
Feb 4, 2014
Q4 2013 Aflac Incorporated Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 11.64% 13.19%
Operating margin 19.13% 21.34%
EBITD margin - 26.12%
Return on average assets 2.24% 2.50%
Return on average equity 18.49% 20.64%
Employees 8,859 -
CDP Score - 85 B


United States - Map
+1-706-3233431 (Phone)
+1-706-3246330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Aflac Incorporated (Aflac) is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services. Its business is supplemental health and life insurance, through its subsidiary, American Family Life Assurance Company of Columbus, which operates in the United States and as a branch in Japan. Aflac�s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including loss-of-income products and products designed to protect individuals from depletion of assets (hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/ critical care, and hospital intensive care plans).

Officers and directors

Daniel P. Amos Chairman of the Board, Chief Executive Officer of the Company and Aflac
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kriss III Cloninger III President, Chief Financial Officer, Treasurer, Director; Chief Financial Officer and EVP of Aflac
Age: 66
Bio & Compensation  - Reuters
Paul Shelby Amos II President of Aflac, Chief Operating Officer - U.S. Operations of Aflac, Director
Age: 38
Bio & Compensation  - Reuters
Masahiko Furutani Deputy President, Aflac Japan
Age: 56
Bio & Compensation  - Reuters
Charles Ditmars Lake II Chairman of Aflac Japan, President of Aflac International
Age: 52
Bio & Compensation  - Reuters
Tohru Tonoike President, Chief Operating Officer of Aflac Japan
Age: 63
Bio & Compensation  - Reuters
Joey M. Loudermilk Executive Vice President, General Counsel of the Company and Aflac
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kenneth S. Janke Jr. Executive Vice President, Deputy Chief Financial Officer; President of Aflac U.S.
Age: 55
Bio & Compensation  - Reuters
Eric M. Kirsch Executive Vice President, Global Chief Investment Officer of Aflac
Age: 53
Bio & Compensation  - Reuters
Audrey Boone Tillman Executive Vice President - Corporate Services
Age: 49
Bio & Compensation  - Reuters